Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 32.48
-1.70 (-4.97%)
Sep 10, 2026, 11:59 AM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 12.57 billion as of September 9, 2026. Its market cap has decreased by -57.88% in one year.
Market Cap
12.57B
Enterprise Value
12.81B
Revenue
741.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.48
ChartMarket Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 12.57B, an increase of 65.70%. That is a compound annual growth rate of 7.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 12.57B | -34.62% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 16.88B |
| HBM Holdings | 12.62B |
| Nanjing Leads Biolabs | 12.35B |
| Everest Medicines | 11.62B |
| Ascletis Pharma | 10.75B |
| GenFleet Therapeutics (Shanghai) | 10.02B |
| Suzhou Ribo Life Science | 9.91B |
| CStone Pharmaceuticals | 9.84B |